Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Prete

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Autoimmunity Reviews|November 8, 2015
Vasculitides: Proposal for an integrated nomenclatureMarcella Prete, Francesco Indiveri, Federico Perosa
Endocrine, Metabolic & Immune Disorders Drug Targets|December 8, 2020
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing PiecesFederico Perosa, Elvira Favoino, Marcella Prete
British Journal of Haematology|December 21, 2002
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myelomaFederico Perosa, Marcella Prete, Grazia Luccarelli, et al.
Reviews in Clinical and Experimental Hematology|May 9, 2003
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myelomaFranco Dammacco, Grazia Luccarelli, Marcella Prete, et al.
Clinical and Experimental Medicine|March 31, 2015
Autoimmune uveitis: clinical, pathogenetic, and therapeutic featuresMarcella Prete, Rosanna Dammacco, Maria Celeste Fatone, et al.
Autoimmunity Reviews|January 15, 2014
Raynaud's phenomenon: from molecular pathogenesis to therapyMarcella Prete, Maria Celeste Fatone, Elvira Favoino, et al.
Autoimmunity Reviews|May 4, 2020
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?Marcella Prete, Elvira Favoino, Giacomo Catacchio, et al.
Blood Cells, Molecules & Diseases|November 11, 2008
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet countFederico Perosa, Carla Minoia, Elvira Favoino, et al.
International Journal of Molecular Sciences|May 14, 2020
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological TreatmentMarcella Prete, Elvira Favoino, Giacomo Catacchio, et al.
International Journal of Molecular Sciences|April 21, 2019
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope SpreadingElvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Autoimmunity Reviews|November 8, 2015
Vasculitides: Proposal for an integrated nomenclatureMarcella Prete, Francesco Indiveri, Federico Perosa
Endocrine, Metabolic & Immune Disorders Drug Targets|December 8, 2020
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing PiecesFederico Perosa, Elvira Favoino, Marcella Prete
British Journal of Haematology|December 21, 2002
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myelomaFederico Perosa, Marcella Prete, Grazia Luccarelli, et al.
Reviews in Clinical and Experimental Hematology|May 9, 2003
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myelomaFranco Dammacco, Grazia Luccarelli, Marcella Prete, et al.
Clinical and Experimental Medicine|March 31, 2015
Autoimmune uveitis: clinical, pathogenetic, and therapeutic featuresMarcella Prete, Rosanna Dammacco, Maria Celeste Fatone, et al.
Autoimmunity Reviews|January 15, 2014
Raynaud's phenomenon: from molecular pathogenesis to therapyMarcella Prete, Maria Celeste Fatone, Elvira Favoino, et al.
Autoimmunity Reviews|May 4, 2020
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?Marcella Prete, Elvira Favoino, Giacomo Catacchio, et al.
Blood Cells, Molecules & Diseases|November 11, 2008
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet countFederico Perosa, Carla Minoia, Elvira Favoino, et al.
International Journal of Molecular Sciences|May 14, 2020
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological TreatmentMarcella Prete, Elvira Favoino, Giacomo Catacchio, et al.
International Journal of Molecular Sciences|April 21, 2019
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope SpreadingElvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Pageof 8